Cargando…
Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of Semaglutide
Early and effective glycemic control can prevent or delay the complications associated with type 2 diabetes (T2D). The benefits of glucagon-like peptide-1 receptor agonists (GLP-1RAs) are becoming increasingly recognized and they now feature prominently in international T2D treatment recommendations...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276717/ https://www.ncbi.nlm.nih.gov/pubmed/34267725 http://dx.doi.org/10.3389/fendo.2021.645507 |